Pediatrix Medical Group, Inc. (BMV:MD)
Mexico flag Mexico · Delayed Price · Currency is MXN
323.00
+26.00 (8.75%)
At close: Oct 31, 2025

Pediatrix Medical Group Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
165.39-99.07-60.4166.34130.96
Depreciation & Amortization
21.8332.2336.1735.6432.15
Loss (Gain) From Sale of Assets
-20.919.7---7.28
Asset Writedown & Restructuring Costs
-178.44148.31--
Loss (Gain) From Sale of Investments
--20--
Stock-Based Compensation
18.0511.8712.3216.1318.97
Other Operating Activities
48.56-4.151.3132.39-37.67
Change in Accounts Receivable
30.5610.2926.28-5.54-72.73
Change in Accounts Payable
28.3351.14-11.920.4221.33
Change in Income Taxes
-1.21-5.04-21.6818.23-2.29
Change in Other Net Operating Assets
-15.8531.84-4.3118.7330.32
Operating Cash Flow
271.09206.57137.33166.9476.74
Operating Cash Flow Growth
31.23%50.43%-17.74%117.55%-62.50%
Capital Expenditures
-18.46-22.02-33.33-29.71-32.25
Sale of Property, Plant & Equipment
----24.73
Cash Acquisitions
-23.2-8.17-6.67-28.17-29.93
Divestitures
30----
Investment in Securities
-3.18-12.05-8.99-0.46-18.56
Other Investing Activities
-3.476.840.811.382.93
Investing Cash Flow
-18.3-35.41-48.18-56.95-53.07
Long-Term Debt Issued
-235.54701,480-
Long-Term Debt Repaid
-20.75-250.89-489.12-1,885-762.66
Net Debt Issued (Repaid)
-20.75-15.39-19.12-405.17-762.66
Issuance of Common Stock
3.183.644.915.46.85
Repurchase of Common Stock
-86.68-1.7-0.92-88.51-4.72
Other Financing Activities
-3.25-1.03-10.590.730.41
Financing Cash Flow
-107.49-14.49-25.72-487.55-760.12
Net Cash Flow
145.3156.6863.43-377.57-736.45
Free Cash Flow
252.63184.55104137.2344.49
Free Cash Flow Growth
36.89%77.46%-24.22%208.47%-74.70%
Free Cash Flow Margin
13.20%9.17%5.21%6.96%2.33%
Free Cash Flow Per Share
2.962.211.261.630.52
Cash Interest Paid
34.384042.28116.2486.54
Cash Income Tax Paid
1.724.730.826.9154.73
Levered Free Cash Flow
190.33173.9269.2136.0861.19
Unlevered Free Cash Flow
212.81199.3995.5160.89104.14
Change in Working Capital
41.8388.24-11.6331.83-23.37
Source: S&P Global Market Intelligence. Standard template. Financial Sources.